Gbedande K, Carpio V, Stephens R
Immunol Rev. 2020; 293(1):88-114.
PMID: 31903675
PMC: 7540220.
DOI: 10.1111/imr.12835.
Heide J, Vaughan K, Sette A, Jacobs T, Schulze Zur Wiesch J
Front Immunol. 2019; 10:397.
PMID: 30949162
PMC: 6438266.
DOI: 10.3389/fimmu.2019.00397.
Moris P, Jongert E, van der Most R
Hum Vaccin Immunother. 2017; 14(1):17-27.
PMID: 28934066
PMC: 5791571.
DOI: 10.1080/21645515.2017.1381809.
Ayieko C, Ogola B, Ochola L, Ngwena G, Ayodo G, Hodges J
PeerJ. 2017; 5:e2855.
PMID: 28097063
PMC: 5228499.
DOI: 10.7717/peerj.2855.
Carapau D, Mitchell R, Nacer A, Shaw A, Othoro C, Frevert U
Infect Immun. 2013; 81(12):4350-62.
PMID: 24042110
PMC: 3837993.
DOI: 10.1128/IAI.00263-13.
Immunization with apical membrane antigen 1 confers sterile infection-blocking immunity against Plasmodium sporozoite challenge in a rodent model.
Schussek S, Trieu A, Apte S, Sidney J, Sette A, Doolan D
Infect Immun. 2013; 81(10):3586-99.
PMID: 23836827
PMC: 3811765.
DOI: 10.1128/IAI.00544-13.
A statistical interaction between circumsporozoite protein-specific T cell and antibody responses and risk of clinical malaria episodes following vaccination with RTS,S/AS01E.
Ndungu F, Mwacharo J, Kimani D, Kai O, Moris P, Jongert E
PLoS One. 2013; 7(12):e52870.
PMID: 23300801
PMC: 3531328.
DOI: 10.1371/journal.pone.0052870.
Single DermaVir immunization: dose-dependent expansion of precursor/memory T cells against all HIV antigens in HIV-1 infected individuals.
Lisziewicz J, Bakare N, Calarota S, Banhegyi D, Szlavik J, Ujhelyi E
PLoS One. 2012; 7(5):e35416.
PMID: 22590502
PMC: 3348904.
DOI: 10.1371/journal.pone.0035416.
Circumsporozoite-specific T cell responses in children vaccinated with RTS,S/AS01E and protection against P falciparum clinical malaria.
Olotu A, Moris P, Mwacharo J, Vekemans J, Kimani D, Janssens M
PLoS One. 2011; 6(10):e25786.
PMID: 21998698
PMC: 3188575.
DOI: 10.1371/journal.pone.0025786.
Differential cellular recognition of antigens during acute Plasmodium falciparum and Plasmodium vivax malaria.
Salwati E, Minigo G, Woodberry T, Piera K, de Silva H, Kenangalem E
J Infect Dis. 2011; 203(8):1192-1199.
PMID: 21451007
PMC: 4313375.
DOI: 10.1093/infdis/jiq166.
Why functional pre-erythrocytic and bloodstage malaria vaccines fail: a meta-analysis of fully protective immunizations and novel immunological model.
Guilbride D, Gawlinski P, Guilbride P
PLoS One. 2010; 5(5):e10685.
PMID: 20502667
PMC: 2873430.
DOI: 10.1371/journal.pone.0010685.
Stability of interferon-gamma and interleukin-10 responses to Plasmodium falciparum liver stage antigen 1 and thrombospondin-related adhesive protein immunodominant epitopes in a highland population from Western Kenya.
Moormann A, Sumba P, Tisch D, Embury P, King C, Kazura J
Am J Trop Med Hyg. 2009; 81(3):489-95.
PMID: 19706920
PMC: 3634720.
Human T cell recognition of the blood stage antigen Plasmodium hypoxanthine guanine xanthine phosphoribosyl transferase (HGXPRT) in acute malaria.
Woodberry T, Pinzon-Charry A, Piera K, Panpisutchai Y, Engwerda C, Doolan D
Malar J. 2009; 8:122.
PMID: 19500406
PMC: 2700129.
DOI: 10.1186/1475-2875-8-122.
T cell responses to mycobacterial catalase-peroxidase profile a pathogenic antigen in systemic sarcoidosis.
Chen E, Wahlstrom J, Song Z, Willett M, Wiken M, Yung R
J Immunol. 2008; 181(12):8784-96.
PMID: 19050300
PMC: 2700300.
DOI: 10.4049/jimmunol.181.12.8784.
Ex vivo characterization of polyclonal memory CD8+ T-cell responses to PRAME-specific peptides in patients with acute lymphoblastic leukemia and acute and chronic myeloid leukemia.
Rezvani K, Yong A, Tawab A, Jafarpour B, Eniafe R, Mielke S
Blood. 2008; 113(10):2245-55.
PMID: 18988867
PMC: 2652370.
DOI: 10.1182/blood-2008-03-144071.
Preclinical assessment of the receptor-binding domain of Plasmodium vivax Duffy-binding protein as a vaccine candidate in rhesus macaques.
Moreno A, Caro-Aguilar I, Yazdani S, Shakri A, Lapp S, Strobert E
Vaccine. 2008; 26(34):4338-44.
PMID: 18573299
PMC: 2532489.
DOI: 10.1016/j.vaccine.2008.06.010.
Correlation of memory T cell responses against TRAP with protection from clinical malaria, and CD4 CD25 high T cells with susceptibility in Kenyans.
Todryk S, Bejon P, Mwangi T, Plebanski M, Urban B, Marsh K
PLoS One. 2008; 3(4):e2027.
PMID: 18446217
PMC: 2323567.
DOI: 10.1371/journal.pone.0002027.
Single-dose protection against Plasmodium berghei by a simian adenovirus vector using a human cytomegalovirus promoter containing intron A.
Sridhar S, Reyes-Sandoval A, Draper S, Moore A, Gilbert S, Gao G
J Virol. 2008; 82(8):3822-33.
PMID: 18256155
PMC: 2293012.
DOI: 10.1128/JVI.02568-07.
The induction and persistence of T cell IFN-gamma responses after vaccination or natural exposure is suppressed by Plasmodium falciparum.
Bejon P, Mwacharo J, Kai O, Todryk S, Keating S, Lowe B
J Immunol. 2007; 179(6):4193-201.
PMID: 17785859
PMC: 2658805.
DOI: 10.4049/jimmunol.179.6.4193.
Cellular immune responses induced with dose-sparing intradermal administration of HIV vaccine to HIV-uninfected volunteers in the ANRS VAC16 trial.
Launay O, Durier C, Desaint C, Silbermann B, Jackson A, Pialoux G
PLoS One. 2007; 2(8):e725.
PMID: 17712402
PMC: 1942115.
DOI: 10.1371/journal.pone.0000725.